StockData
Prestige Consumer Healthcare Inc. logo

Prestige Consumer Healthcare Inc. (PBH) stock

PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$50.62+2.40 (+4.98%)

Close on Nov 18, 2026Market cap $2.40BP/E 14.2Yield –

Prestige Consumer Healthcare total assets

Total assets on the balance sheet at the end of each period.

Prestige Consumer Healthcare's total assets was $4.57B at Jun 30, 2026. For fiscal 2026 it was $3.49B, up 2.7% from the year before. Over ten years it grew 1.7% a year on average. The highest annual figure on record is $3.91B in fiscal 2017.

Annual total assets

PeriodPeriod endValueChange
FY2026Mar 31, 2026$3.49B+2.7%
FY2025Mar 31, 2025$3.40B+2.5%
FY2024Mar 31, 2024$3.32B-1.1%
FY2023Mar 31, 2023$3.35B-8.6%
FY2022Mar 31, 2022$3.67B+7.0%
FY2021Mar 31, 2021$3.43B-2.4%
FY2020Mar 31, 2020$3.51B+2.1%
FY2019Mar 31, 2019$3.44B-8.5%
FY2018Mar 31, 2018$3.76B-3.9%
FY2017Mar 31, 2017$3.91B+32.6%
FY2016Mar 31, 2016$2.95B+11.6%
FY2015Mar 31, 2015$2.64B+47.1%
FY2014Mar 31, 2014$1.80B+3.2%
FY2013Mar 31, 2013$1.74B-1.1%
FY2012Mar 31, 2012$1.76B+66.4%
FY2011Mar 31, 2011$1.06B–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$4.57B+33.1%
Q4 FY2026CQ1 2026Mar 31, 2026$3.49B+2.7%
Q3 FY2026CQ4 2025Dec 31, 2025$3.49B+5.0%
Q2 FY2026CQ3 2025Sep 30, 2025$3.44B+3.8%
Q1 FY2026CQ2 2025Jun 30, 2025$3.43B+3.8%
Q4 FY2025CQ1 2025Mar 31, 2025$3.40B+2.5%
Q3 FY2025CQ4 2024Dec 31, 2024$3.33B-0.3%
Q2 FY2025CQ3 2024Sep 30, 2024$3.32B-0.5%
Q1 FY2025CQ2 2024Jun 30, 2024$3.31B-1.1%
Q4 FY2024CQ1 2024Mar 31, 2024$3.32B-1.1%
Q3 FY2024CQ4 2023Dec 31, 2023$3.34B-10.9%
Q2 FY2024CQ3 2023Sep 30, 2023$3.33B-9.4%
Q1 FY2024CQ2 2023Jun 30, 2023$3.35B-9.1%
Q4 FY2023CQ1 2023Mar 31, 2023$3.35B-8.6%
Q3 FY2023CQ4 2022Dec 31, 2022$3.75B+2.5%
Q2 FY2023CQ3 2022Sep 30, 2022$3.68B+0.1%
Q1 FY2023CQ2 2022Jun 30, 2022$3.68B+3.5%
Q4 FY2022CQ1 2022Mar 31, 2022$3.67B+7.0%
Q3 FY2022CQ4 2021Dec 31, 2021$3.66B+5.5%
Q2 FY2022CQ3 2021Sep 30, 2021$3.68B+7.0%
Q1 FY2022CQ2 2021Jun 30, 2021$3.56B+3.2%
Q4 FY2021CQ1 2021Mar 31, 2021$3.43B-2.4%
Q3 FY2021CQ4 2020Dec 31, 2020$3.47B+0.1%
Q2 FY2021CQ3 2020Sep 30, 2020$3.43B-0.9%
Q1 FY2021CQ2 2020Jun 30, 2020$3.45B-0.3%
Q4 FY2020CQ1 2020Mar 31, 2020$3.51B+2.1%
Q3 FY2020CQ4 2019Dec 31, 2019$3.46B-5.6%
Q2 FY2020CQ3 2019Sep 30, 2019$3.46B-6.3%
Q1 FY2020CQ2 2019Jun 30, 2019$3.46B-8.2%
Q4 FY2019CQ1 2019Mar 31, 2019$3.44B-8.5%
Q3 FY2019CQ4 2018Dec 31, 2018$3.67B-5.9%
Q2 FY2019CQ3 2018Sep 30, 2018$3.70B-5.2%
Q1 FY2019CQ2 2018Jun 30, 2018$3.77B-3.4%
Q4 FY2018CQ1 2018Mar 31, 2018$3.76B-3.9%
Q3 FY2018CQ4 2017Dec 31, 2017$3.90B+38.7%
Q2 FY2018CQ3 2017Sep 30, 2017$3.90B+37.8%
Q1 FY2018CQ2 2017Jun 30, 2017$3.90B–
Q4 FY2017CQ1 2017Mar 31, 2017$3.91B–
Q3 FY2017CQ4 2016Dec 31, 2016$2.81B–
Q2 FY2017CQ3 2016Sep 30, 2016$2.83B–

More Prestige Consumer Healthcare figures

See a number that looks wrong?